Not applicableStudy completedNCT03348891What this trial is testingTNF in Melanoma Patients Treated With ImmunotherapyWho this might be right forMelanoma Institut Claudius Regaud 60
Testing effectiveness (Phase 2)Study completedNCT04740190What this trial is testingTalazoparib - Carboplatin for Recurrent High-grade Glioma With DDRdWho this might be right forRecurrent GliomaRecurrent GlioblastomaPoly ADP Ribose Polymerase (PARP) Inhibitor+2 more The University of Hong Kong 33
Testing effectiveness (Phase 2)Study completedNCT01183897What this trial is testing3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in Bone MarrowWho this might be right forNeuroblastoma Memorial Sloan Kettering Cancer Center 31
Not applicableUnknownNCT05796960What this trial is testingEuropean Multicenter Study on Surgical Management of Advanced Thyroid CancerWho this might be right forThyroid CarcinomaThyroid CancerThyroid Neoplasms+4 more Fondazione Policlinico Universitario Agostino Gemelli IRCCS 3,917
Not applicableUnknownNCT03545542What this trial is testingInvestigating the Microbiome and Volatile Organic Compound Profile of Children With NeuroblastomaWho this might be right forMicrobial ColonizationNeuroblastomaChildren, Only Medical University of Graz 20
Not applicableLooking for participantsNCT06643286What this trial is testingEvaluation of a Personalised Survivorship Care Plan App for Patients With MelanomaWho this might be right forMelanoma (Skin)Melanoma, Stage II, Stage IMelanoma Stage+1 more Erasmus Medical Center 180
Very early researchLooking for participantsNCT06829173What this trial is testingConcurrent XRD-0394 With Radiation Therapy for High Grade GliomasWho this might be right forHigh-Grade Glioma NYU Langone Health 39
Early research (Phase 1)Study completedNCT01176474What this trial is testingVaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV MelanomaWho this might be right forMelanoma (Skin) H. Lee Moffitt Cancer Center and Research Institute 73
Large-scale testing (Phase 3)Looking for participantsNCT02582697What this trial is testingAccelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell TumoursWho this might be right forGerm Cell Tumor University of Sydney 500
Not applicableWithdrawnNCT03708913What this trial is testingNeuromodulation for Hypothalamic ObesityWho this might be right forCraniopharyngiomaHypothalamic ObesityMetabolic Syndrome University of British Columbia
Testing effectiveness (Phase 2)Study completedNCT00938223What this trial is testingEvaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced MelanomaWho this might be right forMelanoma Craig L Slingluff, Jr 51
Testing effectiveness (Phase 2)Looking for participantsNCT05423262What this trial is testingTRK-950 in Patients With Advanced Solid TumorsWho this might be right forSolid TumorMelanoma Toray Industries, Inc 49
Testing effectiveness (Phase 2)Study completedNCT05217303What this trial is testingHL-085 in NRAS-mutated Advanced MelanomaWho this might be right forMelanoma Shanghai Kechow Pharma, Inc. 100
Early research (Phase 1)Looking for participantsNCT06660420What this trial is testingPhase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)Who this might be right forPhase 1Recurrent MelanomaRefractory Melanoma M.D. Anderson Cancer Center 39
Very early researchUnknownNCT04041882What this trial is testing68Ga-DOTATATE PET/CT in Neuroendocrine TumorWho this might be right forNeuroendocrine Tumors Peking Union Medical College Hospital 100
Early research (Phase 1)Study completedNCT00052780What this trial is testingTemozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsWho this might be right forChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+22 more National Cancer Institute (NCI) 72
Not applicableStudy completedNCT00889980What this trial is testingMelanoma Molecular Profiling AnalysisWho this might be right forMelanoma University of Pittsburgh 237
Testing effectiveness (Phase 2)WithdrawnNCT01788280What this trial is testingPreliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With BevacizumabWho this might be right forGlioblastoma Multiforme (GBM) University of Utah
Early research (Phase 1)Study completedNCT02323880What this trial is testingSelinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade GliomasWho this might be right forMalignant GliomaRecurrent Brain NeoplasmRecurrent Childhood Central Nervous System Neoplasm+7 more Children's Oncology Group 59
Not applicableStudy completedNCT00416988What this trial is testingEducational Program in Skin Self-Examination To Detect Melanoma in Healthy ParticipantsWho this might be right forMelanoma (Skin)Weight Changes Rhode Island Hospital 1,135